Correction: Evaluation of Safety, Pharmacokinetic, and Pharmacodynamic Characteristics of a Novel Dual mGluR5/5‑HT2AR Antagonist (VVZ‑2471) in a Randomized, Double‑Blind, First‑in‑Human Study
本文未提供摘要，请点击“查看全文”查看完整内容。